European Medical Solutions (STU:AS00) Other Stockholders Equity: €-94.48 Mil (As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
48 GF Score
Price €4.72
GF Value €8.16
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Other Stockholders Equity?

European Medical Solutions STU:AS00 48 Other Stockholders Equity is €-94.48 Mil as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 48/100 and a GF Value™ of €8.16. The stock has 2 warning signs investors should review.

European Medical Solutions's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €-94.48 Mil.

European Medical Solutions's quarterly Other Stockholders Equity increased from Dec. 2024 (€-94.91 Mil) to Jun. 2025 (€-94.51 Mil) and increased from Jun. 2025 (€-94.51 Mil) to Dec. 2025 (€-94.48 Mil).

European Medical Solutions's annual Other Stockholders Equity declined from Dec. 2023 (€-94.10 Mil) to Dec. 2024 (€-94.91 Mil) but then increased from Dec. 2024 (€-94.91 Mil) to Dec. 2025 (€-94.48 Mil).

European Medical Solutions Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions Other Stockholders Equity Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.84 -88.48 -94.10 -94.91 -94.48

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -94.10 -94.90 -94.91 -94.51 -94.48
STU:AS00
48GF Score
European Medical Solutions STU:AS00
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-94.48 Mil mean?
European Medical Solutions (STU:AS00) has a Other Stockholders Equity of €-94.48 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on European Medical Solutions and its competitors.
Is European Medical Solutions' Other Stockholders Equity too high?
European Medical Solutions' current Other Stockholders Equity is €-94.48 Mil. Overall, European Medical Solutions has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Other Stockholders Equity compare to VRTX and REGN?
European Medical Solutions' Other Stockholders Equity of €-94.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current Other Stockholders Equity is €-94.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Other Stockholders Equity of €-94.48 Mil. The stock's GF Value™ is €8.16, compared to a current price of €4.72 — trading 42.2% below its estimated fair value. The current Other Stockholders Equity is €-94.48 Mil. European Medical Solutions' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Other Stockholders Equity is €-94.48 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.72 is trading 42.2% below its estimated GF Value™ of €8.16.

Key valuation signals for STU:AS00:

  • Other Stockholders Equity: €-94.48 Mil
  • GF Value™: €8.16 vs. price of €4.72 (42.2% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
48GF Score

Get the complete analysis for STU:AS00

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.72
Price
€8.16
GF Value